DUNEX has a strong and diversified business model of marketing, with strategic presence in 20+ countries in global markets with tailored strategies focusing on manufacturing and marketing pharmaceutical & healthcare products and customer satisfaction.
Our “sustainable business” model has achieved through purely organic growth. Our Global markets’ sales are aided by Middle East and South-East Asia, Africa, CIS, and Latin America markets.
DUNEX have over 80+ registered and a strong pipeline with over 140+ under registration across global markets. Our growth is set to be accelerated through tablets, capsules, injections, dry powder injection, syrup, dry syrup, ointments, cream, and effervescent products, with a portfolio of products that are both differentiated and complex.